protein

Recombinant Hepatitis C Virus NS3 Genotype-1b (1356-1459)

MBS142564

0.1 mg

225 USD

Recombinant Protein

Recombinant Hepatitis C Virus NS3 Genotype-1b (1356-1459)

Hepatitis C Virus NS3 Genotype-1b

HCV NS3 Genotype-1b; Hepatitis C Virus NS3 Genotype-1b, (1356-1459 a.a.) Recombinant; HCV NS3 Genotype-1b

HCV

Immunoreactive with sera of HCV-infected individuals.

HCV NS3 Genotype-1b protein is >95% pure as determined by 10% PAGE (coomassie staining). HCV NS3 Genotype-1b protein was purified by proprietary chromatographic technique.

1.5M urea, 25mM Tris-HCl pH-8, 0.2% Triton-X & 50% Glycerol.

NS3 Genotype-1b although stable at 4 degree C for 1 week, should be stored below -18 degree C. Please prevent freeze thaw cycles.

ELISA (EIA), Western Blot (WB)

HCV NS3 Genotype-1b antigen is suitable for ELISA and Western blots, excellent antigen for detection of HCV with minimal specificity problems.

VIRAL ANTIGENS- HEPATITIS C VIRUS; Viral Antigens; Hepatitis C

Description: The E Coli derived recombinant protein contains the HCV NS3 immunodominant regions, amino acids 1356-1459. The protein is fused to a 22kda proprietary GST tag at N-Terminus. Introduction: HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae.HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6).

0.1 mg

225 USD

0.5 mg

645

1 mg

1220